FindTrial
Sign In

To know the effectiveness of different origin bone graft material in earlier formation of bone in bone defects after removal of disease.

An evaluation of egg shell derived hydroxyapatite as bone graft substitute in the healing of maxillary cystic bone defects - a clinical study.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2014/09/004947
Enrollment
20
Registered
2014-09-01
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Patients who requires bone grafting after cystectomy or apicoectony .

Interventions

Intervention1: Egg shell derived hydroxyapatite: The hydroxyapatite crystals will be grafted in cystic bone defects depending on size of lesion. example- average 2X2 cm lesions require 10 cc of graft

Sponsors

DrVivekanand Kattimani
Lead Sponsor
Prof Dr Sampat Kumar
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Patients with periapical cyst diagnosed clinically and radiologically,who required cystectomy and grafting .

Exclusion criteria

Exclusion criteria: Medically compromised patients. Patients with metabolic diseases e.g.diabetes.

Design outcomes

Primary

MeasureTime frame
Enhanced bone healingTimepoint: 4-8 weeks—

Secondary

MeasureTime frame
Good bone density, early bone formation, less pain. No infectionTimepoint: 4-8 weeks—

Countries

India

Contacts

Public ContactDr Vivekanand Kattimani

SIBAR institute of dental sciences

drvivekanandsk@gmail.com09912400988

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026